Blood Test Shows Superior Sensitivity for Early-Stage Liver Cancer Detection
Oncoguard Liver test demonstrates seven times greater sensitivity for very early-stage hepatocellular carcinoma compared to ultrasound surveillance.
Read MorePosted by CLP Edit Staff | Nov 7, 2025 | Cancer |
Oncoguard Liver test demonstrates seven times greater sensitivity for very early-stage hepatocellular carcinoma compared to ultrasound surveillance.
Read MorePosted by CLP Edit Staff | Nov 6, 2025 | Cancer |
TAPS+ chemistry preserves DNA integrity in challenging samples including FFPE tissue and circulating tumor DNA.
Read MorePosted by CLP Edit Staff | Nov 6, 2025 | Dementias & Alzheimer’s |
The validation enables its use as a blood-based biomarker for inclusion and exclusion in clinical trials in both the United States and Europe.
Read MorePosted by CLP Edit Staff | Nov 3, 2025 | Flu & Respiratory Infections |
Sample-to-answer assay delivers results in approximately 45 minutes from nasopharyngeal and nasal swab specimens.
Read MorePosted by CLP Edit Staff | Oct 29, 2025 | Library Preparation Systems Flow |
New plate-based multiplexing can profile up to 384 samples and 100 million cells per week.
Read More